Fiscal Period | 2024 |
---|---|
Period End Date | Sep 23 |
Revenue | 1363.16 |
Total Revenue | 1363.16 |
Costof Revenue Total | 279.79 |
Gross Profit | 1083.37 |
Selling/ General/ Admin Expenses Total | 513.07 |
Depreciation/ Amortization | 57.88 |
Other Operating Expenses Total | 182.95 |
Total Operating Expense | 1033.69 |
Operating Income | 329.47 |
Interest Inc( Exp) Net- Non- Op Total | -85.30 |
Other Net | 45.48 |
Net Income Before Taxes | 366.42 |
Provisionfor Income Taxes | 89.74 |
Net Income After Taxes | 276.68 |
Net Income Before Extra Items | 276.68 |
Net Income | 276.68 |
Income Availableto Com Excl Extra Ord | 276.68 |
Income Availableto Com Incl Extra Ord | 276.68 |
Diluted Net Income | 276.68 |
Diluted Weighted Average Shares | 97.42 |
Diluted EPS Excluding Extra Ord Items | 2.84 |
DPS- Common Stock Primary Issue | 0.00 |
Diluted Normalized EPS | 2.84 |
Max Healthcare Institute Dividend | Max Healthcare Institute Bonus | Max Healthcare Institute News | Max Healthcare Institute AGM | Max Healthcare Institute Rights | Max Healthcare Institute Splits | Max Healthcare Institute Board Meetings | Max Healthcare Institute Key Metrics | Max Healthcare Institute Shareholdings | Max Healthcare Institute Profit Loss | Max Healthcare Institute Balance Sheet | Max Healthcare Institute Cashflow | Max Healthcare Institute Q1 Results | Max Healthcare Institute Q3 Results | Max Healthcare Institute Q4 Results
Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks